About
Ocular drug delivery system
Areas of Focus
Categories
Drug Delivery & Formulation
Clinical Trials (15)
View allTotal Trials
15
As Lead Sponsor
15
As Collaborator
0
Total Enrollment
886
By Phase
NA: 1PHASE2: 13
By Status
COMPLETED: 13TERMINATED: 1WITHDRAWN: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04962009Lead Sponsor
Safety and Intraocular Lowering Effect of Delivery of Travoprost Evolute® in Subjects With Elevated Intraocular Pressure
N/ACompleted
12 participants
Started: Sep 8, 2021 · Completed: Jul 15, 2022
NCT04280653Lead Sponsor
An Open-Label, Multi-Center, Clinical Study Evaluating the Effect of the NDE L68 StableFit® Punctal Plug on the Tear Lake
NACompleted
15 participants
Started: Aug 28, 2019 · Completed: Dec 11, 2019
NCT03496467Lead Sponsor
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract
PHASE2Completed
56 participants
Started: Mar 5, 2018 · Completed: Dec 17, 2018
NCT02014142Lead Sponsor
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
PHASE2Completed
86 participants
Started: Dec 31, 2013 · Completed: Dec 31, 2016
NCT01481051Lead Sponsor
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
PHASE2Completed
57 participants
Started: Nov 30, 2011 · Completed: Sep 30, 2012
Locations (1)
Headquarters
Burnaby, BC, Canada
Map
Loading map...